Select Biosciences Ltd

BioImagene Develops Companion Algorithms™ to Further Enable Personalized Medicine
Company provides Companion Algorithms™ to advance its personalized medicine and the clinical practice of pathology.

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients.

deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
Findings offer promising target for drugs to better regulate calcium metabolism, are integrated into deCODEme™.

deCODE-led Mega-study Finds new Genetic Clues to Causes of Schizophrenia
Findings expand knowledge of the biology of the disease and provide potential new drug targets.

Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway acquires worldwide commercial rights for three investigational dermatological molecules from Pfizer.

Panic attack and suicide risk: A multivariate logistic regression analysis of a national epidemiological survey
Beth Israel Medical Center, Johns Hopkins University

To examine the relationship between panic attack and suicide risk, we analyzed data from a representative epidemiological survey of 43,093 adults (NESARC) using logistic regression controlling for socio-demographic and clinical variables. In depression, panic attacks are associated with increased odds of suicide attempt even after controlling for demographic and clinical variables. Furthermore, panic attacks can differentiate those who attempt suicide from those with ideation only.

Panic attack and suicide risk: A multivariate logistic regression analysis of a national epidemiological survey
Beth Israel Medical Center, Johns Hopkins University

To examine the relationship between panic attack and suicide risk, we analyzed data from a representative epidemiological survey of 43,093 adults (NESARC) using logistic regression controlling for socio-demographic and clinical variables. In depression, panic attacks are associated with increased odds of suicide attempt even after controlling for demographic and clinical variables. Furthermore, panic attacks can differentiate those who attempt suicide from those with ideation only.

SYBR® Green I as a biomarker for schizophrenia
Islamic Azad University of Tonekabon

The purpose of this study were to examine if the mRNA of the peripheral dopamine receptor is changed in schizophrenia patients. 50 Naive patients were enrolled. After extracting RNA from white blood cells, cDNA is synthesized. After doing the quantitative Real-time PCR, expression of D3 receptors in healthy persons and patients were compared. Results of this examinations reveals that expression of D3 receptor is increased in compared with controls sample.

Senior Director ADME
The RSA Group
Hatfield, Herts, UK

Mass Spectometry Scientist
Roswell Park Cancer Institute
Buffalo, NY, USA

Principal HTS Scientist
St. Jude Childrens Research Hospital
Memphis, TN, USA


Target Discovery World Congress, South San Francisco, CA, USA
04 August 2009 - 05 August 2009

Target Discovery World Congress will be a meeting focusing on the research looking to find new potential drugs for development. The topics will include presentations on the latest in screening platforms and new methods such as those in High Content and Label-Free Screening and will also focus on the work being done looking for new drug targets in some of the major protein families including Ion Channels, GPCRs, Protein Kinases, Nuclear Receptors and the Ubiquitin Pathway.

Molecular Diagnostics World Congress, South San Franscisco, CA, USA
06 August 2009 - 07 August 2009

Welcome to the 2nd Molecular Diagnostics World Congress, this year's event will take place at the South San Francisco Conference Center.

Drug Delivery, London, England
02 September 2009 - 02 September 2009

The summit includes three one-day symposia on the following subjects: Delivery of Small Molecules & Nucleic Acids, Delivery of Macromolecules and Formulation & Solubility
  


IP Update: Patentability of Stem Cell Inventions in Europe

Nick Bassil, Patent Attorney, Kilburn & Strode, speaking at the Stem Cells World Congress 2008


Patentability of Embroynic Stem Cells

Philippa Montgomerie, Associate, DLA Piper Scotland, speaking at the Stem Cells World Congress 2008


Terms of Engagement: Knowledge Transfer Between Industry and Academia

Jolyon White, Technology Consultant, London Technology Network, speaking at the Stem Cells World Congress 2008

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Stem Cells for Cardiovascular Disease 2009
Select Biosciences Ltd

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects of stem cells being developed for addressing the opportunities in the cardio and vascular disease spaces.